Genetic polymorphism of CYP2C9 and CYP2C19 in a Bolivian population: an investigative and comparative study-Reference-Cited by-同舟云学术

Genetic polymorphism of CYP2C9 and CYP2C19 in a Bolivian population: an investigative and comparative study

Published:2005-03-18 Issue:3 Volume:61 Page:179-184
ISSN:0031-6970
Container-title:European Journal of Clinical Pharmacology
language:en
Short-container-title:Eur J Clin Pharmacol

Author:

Bravo-Villalta Heydy V.,Yamamoto Koujirou,Nakamura Katsunori,Bayá Ana,Okada Yuko,Horiuchi Ryuya

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00228-004-0890-5.pdf

Reference55 articles.

1. Meehan RR, Gosden JR, Rout D et al (1988) Human cytochrome P-450 PB-I: a multigene family involved in mephenytoin and steroid oxidations that maps to chromosome 10. Am J Hum Genet 42:26–37

2. Gray IC, Nobile C, Muresu R, Ford S, Spurr NK (1995) A 2.4-megabase physical map spanning the CYP2C gene cluster on chromosome 10q24. Genomics 28:328–332

3. Goldstein JA, de Morais SM (1994) Biochemistry and molecular biology of the human CYP2C subfamily. Pharmacogenetics 4:285–299

4. Miners JO, Birkett DJ (1998) Cytochrome P4502C9: an enzyme of major importance in human drug metabolism. Br J Clin Pharmacol 45:525–538

5. Takahashi H, Echizen H (2001) Pharmacogenetics of warfarin elimination and its clinical implications. Clin Pharmacokinet 40:587–603

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Population Pharmacokinetics of Sertraline in Psychiatric and Substance Use Disorders;The Journal of Clinical Pharmacology;2024-05-08

2. Genetic polymorphisms of CYP2C19 in ecuadorian population: An interethnic approach;Heliyon;2024-04

3. CYP2C19 *2/*2 Genotype is a Risk Factor for Multi-Site Arteriosclerosis: A Hospital-Based Cohort Study;International Journal of General Medicine;2023-11

4. Differences in the Proportion of CYP2C19 Loss-of-Function Between Cerebral Infarction and Coronary Artery Disease Patients;International Journal of General Medicine;2023-08

5. CYP2C19 loss-of-function is associated with increased risk of hypertension in a Hakka population: a case-control study;BMC Cardiovascular Disorders;2023-04-06